Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002

Vaccine. 2004 May 7;22(15-16):1836-41. doi: 10.1016/j.vaccine.2003.11.051.

Authors

I Knezevic¹, E Griffiths, F Reigel, R Dobbelaer

Affiliation

¹ Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. [email protected]

PMID: 15168689
DOI: 10.1016/j.vaccine.2003.11.051

No abstract available

MeSH terms

Encephalitis Viruses, Tick-Borne / immunology
Europe
Legislation, Drug*
Preservatives, Pharmaceutical / adverse effects*
Thimerosal / adverse effects*
United States
Vaccines / adverse effects*

Substances

Preservatives, Pharmaceutical
Vaccines
Thimerosal